Vuong Trieu - Net Worth and Insider Trading

Vuong Trieu Net Worth

The estimated net worth of Vuong Trieu is at least $4 Million dollars as of 2024-12-01. Vuong Trieu is the CHAIRMAN AND CEO, 10% Owner of Oncotelic Therapeutics Inc and owns about 116,495,629 shares of Oncotelic Therapeutics Inc (OTLC) stock worth over $4 Million. Details can be seen in Vuong Trieu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vuong Trieu has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Vuong Trieu

To

Vuong Trieu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vuong Trieu owns 3 companies in total, including Oncotelic Therapeutics Inc (OTLC) , Adhera Therapeutics Inc (ATRX) , and Sorrento Therapeutics Inc (SRNE) .

Click here to see the complete history of Vuong Trieu’s form 4 insider trades.

Insider Ownership Summary of Vuong Trieu

Ticker Comapny Transaction Date Type of Owner
OTLC Oncotelic Therapeutics Inc 2024-08-23 CHIEF EXECUTIVE OFFICER
ATRX Adhera Therapeutics Inc 2016-11-15 director & Chairman of the Board
SRNE Sorrento Therapeutics Inc 2013-09-09 director & Chief Scientific Officer

Vuong Trieu Latest Holdings Summary

Vuong Trieu currently owns a total of 1 stock. Vuong Trieu owns 116,495,629 shares of Oncotelic Therapeutics Inc (OTLC) as of November 22, 2024, with a value of $4 Million.

Latest Holdings of Vuong Trieu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OTLC Oncotelic Therapeutics Inc 2024-11-22 116,495,629 0.03 3,716,211

Holding Weightings of Vuong Trieu


Vuong Trieu Form 4 Trading Tracker

According to the SEC Form 4 filings, Vuong Trieu has made a total of 12 transactions in Oncotelic Therapeutics Inc (OTLC) over the past 5 years, including 12 buys and 0 sells. The most-recent trade in Oncotelic Therapeutics Inc is the acquisition of 298,499 shares on November 22, 2024, which cost Vuong Trieu around $8,955.

Insider Trading History of Vuong Trieu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vuong Trieu Trading Performance

GuruFocus tracks the stock performance after each of Vuong Trieu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vuong Trieu is 0.11%. GuruFocus also compares Vuong Trieu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vuong Trieu within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Vuong Trieu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Vuong Trieu

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.91 LIMIT LIMIT LIMIT LIMIT LIMIT

Vuong Trieu Ownership Network

Ownership Network List of Vuong Trieu

No Data

Ownership Network Relation of Vuong Trieu

Insider Network Chart

Vuong Trieu Owned Company Details

What does Oncotelic Therapeutics Inc do?

Who are the key executives at Oncotelic Therapeutics Inc?

Vuong Trieu is the CHIEF EXECUTIVE OFFICER of Oncotelic Therapeutics Inc. Other key executives at Oncotelic Therapeutics Inc include CHIEF BUSINESS OFFICER Saran Saund , CHIEF FINANCIAL OFFICER Amit B. Shah , and CHIEF TECHNOLOGY OFFICER Chulho Park .

Oncotelic Therapeutics Inc (OTLC) Insider Trades Summary

Over the past 18 months, Vuong Trieu made 4 insider transaction in Oncotelic Therapeutics Inc (OTLC) with a net purchase of 1,398,499.

In summary, during the past 3 months, insiders sold 0 shares of Oncotelic Therapeutics Inc (OTLC) in total and bought 298,499 shares, with a net purchase of 298,499 shares. During the past 18 months, 0 shares of Oncotelic Therapeutics Inc (OTLC) were sold and 1,398,499 shares were bought by its insiders, resulting in a net purchase of 1,398,499 shares.

Oncotelic Therapeutics Inc (OTLC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oncotelic Therapeutics Inc Insider Transactions

No Available Data

Vuong Trieu Mailing Address

Above is the net worth, insider trading, and ownership report for Vuong Trieu. You might contact Vuong Trieu via mailing address: 4003 Jim Bowie Road, Agoura Hills Ca 91301.

Discussions on Vuong Trieu

No discussions yet.